November 14, 2018

On Litigation Funding: The Drug and Device Industry

Tarifa Laddon, Patrick Reilly and Blake Angelino authored an article for In-House Defense Quarterly about the drug and device industry and third-party litigation funding. 
"Drug and device cases are particularly
attractive to litigation funders for several
reasons: the cases are highly visible, easy
to spot, and are relatively easy to collect
en masse. The rise of third-party litigation
funding, the grey area in which it currently
operates, and the growth of it in product
liability cases combine to create very real
risks to drug and device manufacturers. "laddon, reilly and angelino, in-house quarterly
Full Article

The Faegre Baker Daniels website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Baker Daniels' cookies information for more details.